Livongo Health (NASDAQ:LVGO) expects Q2 2020 revenue in the range of $86M to $87M, up from prior guidance of $73M to $75M.
The company will hold a conference call on August 6, at 4:30 p.m. ET to discuss Q2 results and forward guidance.
LVGO +5% PM.
Seeking Alpha authors are currently bullish on the stock, while Wall Street analysts are very bullish.
Looking at momentum, the stock’s price return is nearly 36% in the last three months and more than 210% in the last six months.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.